MMJ Phytotech Ltd., of Perth, Australia, named Stanislav Sologubov CEO of Satipharm Switzerland, its subsidiary, and appointed John Hollister strategic pharmaceutical consultant. As CEO of Satipharm, Sologubov will focus on accelerating sales of Satipharm’s medical cannabis consumer health products in Europe.